Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical history

Omalizumab for severe asthma: toward personalized treatment based on biomarker profile and clinical history

Farnaz Tabatabaian, Dennis K Ledford Division of Allergy and Immunology, Department of Internal Medicine, Morsani College of Medicine, University of South Florida, Tampa, FL, USA Abstract: Asthma is a heterogeneous syndrome with numerous underlining molecular and inflammatory mechanisms contributing...

Full description

Bibliographic Details
Main Authors: Tabatabaian F, Ledford DK
Format: Article
Language:English
Published: Dove Medical Press 2018-04-01
Series:Journal of Asthma and Allergy
Subjects:
Severe persistent asthma
asthma phenotype and endotype
T2 high inflammation
omalizumab
asthma biomarkers
eosinophils
fractional exhaled nitric oxide
IgE
Online Access:https://www.dovepress.com/omalizumab-for-severe-asthma-toward-personalized-treatment-based-on-bi-peer-reviewed-article-JAA

Internet

https://www.dovepress.com/omalizumab-for-severe-asthma-toward-personalized-treatment-based-on-bi-peer-reviewed-article-JAA

Similar Items